Han Zhu (@HanZhuMD) / X

Han Zhu

955 posts

Han Zhu

@HanZhuMD

Cardiologist and #PhysicianScientist at Stanford. Director, Stanford Translational Cardio-Oncology. Cardio-Immunology. MIT and CWRU alum.

Stanford, CA

Joined November 2017

Pinned
Han Zhu
@HanZhuMD
Feb 11, 2025
Proud to share this new pub from my lab - “Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis” ahajournals.org/doi/10.1161/.... Congrats to first authors @yuhsinvhuang and @yinsun96. Our first foray into targeted therapy for this devastating condition
8.3K
Han Zhu
@HanZhuMD
May 1, 2023
It’s official!!🎉🎉🎉🥳Even tho it’s been a gradual transition, it still feels like a big step to see it in writing. I’m full of gratitude for the ppl who have supported/believed in me. Thank you. So excited to continue the research to help our #cardioonc/cardio-immuno patients!
68K
Han Zhu
@HanZhuMD
Jun 28, 2022
Thrilled to share our journey using single-cell multi-omics to do deep immunophenotyping in patients with ICI myocarditis @CircAHA #CardioOnc @SeanM_Wu @SingleCellMedia ahajournals.org/doi/10.1161/CI…
Han Zhu
@HanZhuMD
Jan 6, 2022
Just got official confirmation of receiving my K08. Really excited and grateful for all the friends, mentors, advisors and communities who have supported me in this journey, and also super excited for what’s ahead!! @StanCVFellows @StanfordMedRes @SarnoffCardio @SeanM_Wu
Han Zhu
@HanZhuMD
Apr 22, 2020
Our paper on COVID-19 and CV complications/host immune response is now live! #Cardioimmunology can give us powerful tools to study the effects of the immune system in the heart in topics ranging from cancer therapies to infectious and autoimmune disease doi.org/10.1007/s11886…
Han Zhu
@HanZhuMD
Jul 26, 2024
Proud to announce that we are now an R01 funded lab! We will be using single cell multi-omics in human samples & mouse models to test novel therapeutic pathways in cardiac sarcoidosis. #cardioimmunology @nih_nhlbi @NIH @StanfordCVI @StanfordDeptMed @Joseph_C_Wu @SeanM_Wu @EldrinL
14K
Han Zhu
@HanZhuMD
Jan 5, 2023
Proud to announce that our lab site is live!! Check it out to see what we are about and for job opportunities in our lab & the Stanford Translational Cardio-Oncology Program! 👉🏻hanzhulab.com #cardiooncology #cardioimmunology @StanfordCVI @StanfordMed @StanCVFellows
27K
Han Zhu
@HanZhuMD
Aug 11, 2020
Our paper on the spectrum of cardiotoxicities from immune checkpoint inhibitors is now live! Clinical to basic mouse models of immune mechanisms of T cell toxicities in the heart. Much work to be done in this area still! pubmed.ncbi.nlm.nih.gov/32776859/ #cardiooncology #cardioimmunology
Han Zhu
@HanZhuMD
Aug 11, 2020
Wow! Another piece of exciting news. I've been incredibly lucky to be named a recipient of the Sarnoff Scholar Career Development Award. A huge honor and big shoes to fill. Thank you so much for the amazing opportunities you've provided throughout my training, @SarnoffCardio.
Han Zhu
@HanZhuMD
Feb 10, 2023
Honored to receive the @StanfordCVI Manuscript Award for our pub in @CircAHA! What a great start for our new lab, and of course I'm eternally grateful for the dedicated mentorship of @SeanM_Wu @.PatriciaNguyen @.MarkDavis & the hard work of our team!!
Han Zhu
@HanZhuMD
Jun 28, 2022
Thrilled to share our journey using single-cell multi-omics to do deep immunophenotyping in patients with ICI myocarditis @CircAHA #CardioOnc @SeanM_Wu @SingleCellMedia ahajournals.org/doi/10.1161/CI…
med.stanford.edu
CVI Manuscript Awards
13K
Han Zhu
@HanZhuMD
Feb 2, 2024
Proud to present this pre-print from my lab. Using single-cell multi-omics, 2 mice models, & pt samples, we found CXCR3 as a novel therapeutic target for ICI myocarditis critical for T-cell/macrophage crosstalk and perpetuation of cardiac inflammation
biorxiv.org
A Novel Therapeutic Approach using CXCR3 Blockade to Treat Immune Checkpoint Inhibitor-mediated...
Background Immune checkpoint inhibitors (ICIs) are successful in treating many cancers but may cause immune-related adverse events. ICI-mediated myocarditis has a high fatality rate of up to 40%,...
8.3K
Han Zhu
@HanZhuMD
Oct 3, 2023
Honored to share our work on Osimertinib cardiomyopathy in pts with NSCLC at Stanford, a diagnosis with sig consequences for pts. Great work by Dr. Miguel Franquiz & team #cardioonc @Ron_Witteles @SWaliany @JoelNealMD @HwakeleeMD @Paul_P_Cheng @SeanM_Wu sciencedirect.com/science/articl…
11K
Han Zhu
@HanZhuMD
Jul 22, 2024
Proud of Dr. Yin Sun from my lab who is presenting his work taking the next step to test therapeutic targets for ICI myocarditis in a mouse tumor myocarditis model💪👌🔥 #BCVS24 @AHAMeetings @AHAScience @BCVSearlyCareer
3.2K
Han Zhu
@HanZhuMD
Feb 15, 2020
Honored to have the opportunity to present this at #ACCCardioOnc . Thanks to Stanford Cardio-Onc team members and mentors. @Ron_Witteles @SeanM_Wu @HwakeleeMD @JoelNealMD @SWaliany @JuneWRhee @joshuawknowles @StanfordCVI @StanCVFellows
June Rhee
@JuneWRhee
Feb 15, 2020
An excellent poster by @HanZhuMD on bright early Saturday #ACCCardioOnc ! Asymptomatic ICI patient with trop>10 successfully treated with steroid. @Ron_Witteles @SeanM_Wu @JoelNealMD @SWaliany